Ebola virus disease (EVD) is a severe, often fatal illness in humans. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. Ebola virus has caused the majority of human deaths from EVD, and is the cause of the 2013–2015 Ebola virus epidemic in West Africa, which has resulted in at least 26,969 suspected cases and 11,135 confirmed deaths.
Scientists have come up with a cure for this deadly Ebola virus. And one of the scientists is of Indian origin.
While some researchers are developing vaccines to prevent Ebola infections, others are focusing on the treatment for the disease.
Rekha G Panchal from the US Army Medical Research Institute of Infectious Diseases and colleagues have been looking into possible treatments by studying a class of small molecules called diaza chrysenes.
The researchers narrowed down their search to a handful of diaza chrysenes. In their study, 70%-90% of the mice that received one of three of the experimental compounds survived infection and did not show any obvious side effects. The finding was published in the journal ACS Infectious Diseases.